Immunization Graphs: Natural Infectious Disease Declines; Immunization Effectiveness; and Immunization Dangers

Similar documents
Measles and rubella monitoring January 2015

Safety monitoring of vaccines. Jeremy Labadie MD vaccine safety specialist

Global and National Trends in Vaccine Preventable Diseases. Dr Brenda Corcoran National Immunisation Office.

The Continued Need for Immunizations in Top Ten Causes of Death in the U.S., 1900 vs Common Questions about Vaccines

The Continued Need for Immunizations in 2016

Monthly measles and rubella monitoring report

Roman Bystrianyk, "Flu vaccines for all nursing home patients?", Health Sentinel, August 29, 2005,

EUVAC.NET A surveillance network for vaccine-preventable diseases

Immunisation for pre-school children. three years and four months old

Case Studies in Ecology and Evolution. 10 The population biology of infectious disease

Selected vaccine introduction status into routine immunization

Life expectancy at birth for males

TEMPORARY PROGRAMME PERTUSSIS VACCINATION FOR PREGNANT WOMEN

Contents. Part One Vaccine Use. Acknowledgments

OUR BEST SHOT: The Truth About Vaccines for You and Your Loved Ones VACCINES. Produced in partnership with

Help protect your child. At-a-glance guide to childhood vaccines.

Help protect your child. At-a-glance guide to childhood vaccines.

Sustaining Immunization in Developing Countries: The Future We Make

Vaccines Work Version

Economic aspects of viral hepatitis in Turkey. Levent AKIN VIRAL HEPATITIS PREVENTION BOARD MEETING ISTANBUL, TURKEY, NOVEMBER 12-13, 2009

Controlling Vaccine Preventable Diseases in the US and Global Immunization Efforts

Communicable Disease & Immunization

History and aims of immunisation. Dr Anna Clarke Department of Public Health Dr. Steevens Hospital Dublin 8

CLINICAL PREPAREDNESS PERMIT

To Vaccinate or Not to Vaccinate. time. The spread of infectious disease, like the bubonic plague in

Impact of Immunization on Under 5 Mortality

Immunizations (Guideline Intervals Using The Rule of Six for Vaccines Birth to Six Years)

County of Santa Cruz. General Questions About Measles HEALTH SERVICES AGENCY. Public Health Division. What is measles?

Help protect your child. At-a-glance guide to childhood vaccines.

NHS GRAMPIAN IMMUNISATION PROGRAMMES ANNUAL REPORT 2010/11

Aluminum in Vaccines:

Requirements for new trials to examine offtarget. vaccination. Workshop on: Off-target (heterologous/non-specific) effects of vaccination.

m Public health officials Medical administrators Clinicians

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

Vaccine Preventable Diseases in San Francisco. Susan Fernyak, MD MPH CDCP Section Director and Deputy Health Officer August 17, 2010

Pertussis immunisation for pregnant women

Bio-Rad Laboratories. The Best Protection Whoever You Are. Congenital and Pediatric Disease Testing

Polio Transition Planning: Risks and opportunities of transitioning resources to non-polio public health interventions

Expanded Programme on Immunization (EPI):

The Danish childhood vaccination program SUMMARY IN ENGLISH

Pneumococcal vaccination in UK: an update. Dr Richard Pebody Immunisation Department Health Protection Agency Centre for Infections

CLINICAL PREPAREDNESS PERMIT Practical Nursing Program

The Science of Vaccines:

SHOULD VACCINES BE COMPULSORY?

Annual measles notifications & vaccine coverage England and Wales

Summary of Methods. Figure 1: Vaccines have been very effective in reducing most vaccine-preventable diseases in Colorado.

Introduction to Measles a Priority Vaccine Preventable Disease (VPD) in Africa

Current Incident Status of Vaccine-Preventable Bacterial and Viral Infectious Diseases in Japan

Protecting Infants and Children from Pertussis and Influenza

VACCINES FOR THE COMMON GOOD

Immunizations for Children and Teens with Suppressed Immune Systems

Vaccine-Preventable Diseases in Colorado s Children 2009 Sean O Leary MD, Carl Armon PhD, Joni Reynolds, RNC, MSN, James Todd MD

Undergraduate Medical Education

IOM Committee on Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule

IMMUNISATION. Diseases that can be prevented by immunisation

Immunization and Vaccines

2013 About Pertussis (Whooping Cough)

2017 Vaccine Preventable Disease Summary

Kathleen Arrington, RN Kankakee County Health Department

Mandates and More. Julie Morita, M.D. Deputy Commissioner Chicago Department of Public Health. Chicago Department of Public Health

11 Enforcement of the Immunization of School Pupils Act

Essential Vaccinations for HIV-Positive Adults and Adolescents

TABLE OF CONTENTS. In what way can this educational material help me? Why are vaccinations important? Who needs vaccinations?

Weekly Influenza Surveillance Report. Week 11

Whooping. pregnancy. Your questions answered on how to help protect your baby. the safest way to protect yourself and your baby

No :

European monthly measles monitoring (EMMO)

VACCINES TRIUMPHS AND TRIBULATIONS. William Schaffner, MD Chairman, Department of Preventive Medicine Vanderbilt University School of Medicine

OVERVIEW 2018 VACCINE UPDATE 3/19/ VACCINE SCHEDULE

The schedule for childhood vaccination is:(web link to NHS Childhood Immunisation Schedule for 2008

Childhood immunisation: An Update

Measles vaccine: a 27-year follow-up.

SB 277-mandated vaccines have not yet been proven to be less risky than the diseases they are designed to prevent.

Challenges of use of cholera vaccines in Haiti and the Americas

SCHNEIDER MEDICAL GROUP, PA History Intake Form (Please Print)

New guidelines for the management of norovirus outbreaks in acute and community health and social care settings

Samir K Saha, Ph.D Child Health Research Foundation Dhaka Shishu Hospital Dhaka, Bangladesh

Immunization Update: What s New?

Measles Back in the Spotlight

Vaccination schedules in Denmark

Public perception of the benefits of vaccines anti vaccination lobby

Don t let your child catch it

VI Child Health. Immunisation

3.1 PHASE 2 OF THE GLOBAL PROJECT

Objectives. Immunity. Childhood Immunization Risk of Non-Vaccinated Children 12/22/2015

Gardasil Network Development Project GARDASIL VACCINE QUESTIONNAIRE

I protected my future

Influenza Backgrounder

DISCLOSURES. I have no actual or potential conflicts of interest in this presentation.

Experience with maternal pertussis and PCV13 immunisation in England

2016 Vaccine Preventable Disease Summary

Carga global de la enfermedad neumocócia

HPV Vaccines: Background and Current Status

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

Pandemic H1N1 2009: The Public Health Perspective. Massachusetts Department of Public Health November, 2009

NHS public health functions agreement Service specification No. 31 Meningococcal group B (MenB) programme

Drug-resistant Tuberculosis

A Parent s Guide to Childhood Immunization. Be informed.

NHS public health functions agreement Service specification No.9 DTaP/IPV and dtap/ipv pre-school booster immunisation programme

Transcription:

Immunization Graphs: Natural Infectious Disease Declines; Immunization Effectiveness; and Immunization Dangers Prepared by: Raymond Obomsawin Ph.D. December, 2009

FIGURE SET I. Natural Infectious Disease Declines Preceding Public Immunization Efforts Figures one (1) through eleven (11) graphically illustrate that in North America, Europe, and the South Pacific, major declines in life-threatening infectious diseases occurred historically either without, or far in advance of public immunization efforts for specific diseases as listed. This provides irrefutable evidence that vaccines are not necessary for the effective elimination of a wide range of infectious diseases

800.00 FIGURE 1 CANADA MEASLES REPORTED INCIDENCE (1935-1983) 700.00 600.00 500.00 400.00 300.00 Measles Vaccines Introduced Live 1963 / Inactivated 1964 200.00 100.00 0.00 1935 1947 1959 1971 1983 Source: Adapted from: Public Health Agency of Canada, Figure 8 Measles Reported Incidence Canada. http://www.phac-aspc.gc.ca/publicat/cig-gci/p04-meas-roug-eng.php

1,200.00 FIGURE 2 - ENGLAND & WALES MEAN ANNUAL MEASLES MORTALITY CASES CHILDREN UNDER 15 (1850-1965) 1,000.00 800.00 600.00 Measles Vaccination Begins 400.00 200.00 0.00 1850 1875 1900 1925 1950 1965 Source: McKeown, T., The Role of Medicine: Dream, Mirage or Nemesis?; Basil Blackwell; Oxford, UK; 1979; p. 105; & Waltzkin, H., in The Relevance of Social Science for Medicine; Springer; 1st edition, Dec. 31, 1980

0.14 0.12 FIGURE 3 - ENGLAND SCURVY & MEASLES PARALLEL MORTALITY RATES PER 100,000 (1919-1967) 0.1 0.08 0.06 SCURVY MEASLES 0.04 Measles Vaccination Begins 0.02 0 1919 1925 1931 1937 1943 1949 1955 1961 1967 Sources: Data for years 1919-1967 Mortality Statistics: Deaths Registered in England & Wales; UK Office for National Statistics, 1997.

200.00 FIGURE 4 CANADA TUBERCULOSIS MORTALITY RATES PER 100,000 (1880-1960) 180.00 160.00 140.00 120.00 100.00 80.00 60.00 BCG Vaccination Introduced Between 1948-1954 (Depending on Prov. or Terr.) 40.00 20.00 0.00 1880 1900 1924 1930 1936 1942 1948 1954 1960 Source: Table based on data at: Timeline of TB in Canada http://www.lung.ca/tb/tbhistory/timeline/; http://www.thecanadianencyclopedia.com/index.cfm?pgnm=tce&params=a1arta0008151 Public Health Agency of Canada: http://www.phac-aspc.gc.ca/publicat/cig-gci/p04-bcg-eng.php; and PHAC on BCG usage in Canada: http://www.phac-aspc.gc.ca/tbpc-latb/bcgvac_1206-eng.php

200.00 FIGURE 5 UNITED STATES TUBERCULOSIS MORTALITY RATES PER 100,000 INFANTS (1900-1960) 180.00 160.00 140.00 120.00 100.00 80.00 No Vaccination for Tuberculosis Adopted in the USA 60.00 40.00 20.00 0.00 1900 1910 1920 1930 1940 1950 1960 Source: John H. Dingle; Life and Death in Medicine; Scientific American; 1973; p. 56.

1,400.00 FIGURE 6 - NEW ZEALAND TUBERCULOSIS MORTALITY RATES PER MILLION (1880-1960) 1,200.00 1,000.00 800.00 600.00 BCG Vaccination Introduced 400.00 200.00 0.00 1880 1890 1900 1910 1920 1930 1940 1950 1953 1960 Source: Director General Annual Mortality Reports Covering 1872-1960, New Zealand Parliamentary Journals for the Years Specified.

16.00 FIGURE 7 UNITED STATES MEAN ANNUAL PERTUSSIS MORTALITY RATES PER 100,000 (1918-1960) 14.00 12.00 10.00 8.00 6.00 Pertussis Vaccination Introduced 4.00 2.00 0.00 1918 1924 1930 1936 1942 1948 1954 1960 Source: Data derived from: Vital Statistics of the United States 1937-1960; and Historical Statistics of the United States: Colonial Times to 1970 Part 1 Ch. B Vital Statistics and Health and Medical Care, pp. 44-86H.

FIGURE 8 - ENGLAND & WALES MEAN ANNUAL PERTUSSIS MORTALITY CASES CHILDREN UNDER 15 (1850-1965) 1,400.00 1,200.00 1,000.00 800.00 600.00 Pertussis Vaccination Introduced 400.00 200.00 0.00 1850 1875 1900 1925 1950 1965 Source: Thomas McKeown, The Role of Medicine: Dream, Mirage or Nemesis?; Basil Blackwell; Oxford, UK; 1979; p. 103

0.18 0.16 FIGURE 9 - ENGLAND SCURVY & PERTUSSIS PARALLEL MORTALITY RATES PER 100,000 (1919-1967) 0.14 0.12 0.1 0.08 0.06 SCURVY PERTUSSIS 0.04 0.02 0 Pertussis Vaccination Begins 1919 1925 1931 1937 1943 1949 1955 1961 1967 Sources: Data for years 1919-1967 Mortality Statistics: Deaths Registered in England & Wales; UK Office for National Statistics, 1997.

12.00 FIGURE 10 UNITED STATES MEAN ANNUAL SCARLET FEVER MORTALITY RATES PER 100,000 (1910-1958) 10.00 8.00 6.00 4.00 No Vaccination for Scarlet Fever Adopted in the USA 2.00 0.00 1910 1916 1922 1928 1934 1940 1946 1952 1958 Source: Data derived from - Vital Statistics of the United States 1937-1960; and Historical Statistics of the United States: Colonial Times to 1970 Part 1 Ch. B Vital Statistics and Health and Medical Care, pp. 44-86H.

180.00 FIGURE 11 UNITED STATES ANNUAL INFLUENZA MORTALITY RATES PER 100,000 (1933-1965) 160.00 140.00 120.00 100.00 80.00 60.00 40.00 Influenza vaccination first widely administered in the U.S. in the late 1980s. 20.00 0.00 1933 1937 1941 1945 1949 1953 1961 1965 Source: Doshi, P., Trends in Recorded Influenza Mortality: United States 1900-2004, American Journal of Public Health, May 2008, vol. 98, no. 5, p. 941.

FIGURE SET II. Immunization Effectiveness Figures eleven (12) through twenty-four (24) graphically illustrate that immunization is not by any means a proven and foolproof measure for protection from various infectious disease conditions. It is often inconsequential epidemiologically, and in some cases it is shown to actually worsen health-care outcomes.

Figure 12 Children Under 2 Yrs of Age Inactivated Influenza Vaccine 0% Effective Source: Cochrane Collaboration Database of Systematic Reviews, (John Wiley & Sons, Ltd.) 2006 (1) Article No. CD004879 Covers 51 Studies on 260,000 children Figure 13 Elderly Living in Communities & Group Homes Inactivated Influenza Vaccine Little or No Effectiveness Source: Cochrane Collaboration Database of Systematic Reviews, (John Wiley & Sons, Ltd.) 2006 (3) Article No. CD004876 Covers 64 Studies, over 40 years of infuenza vaccination and see: http://www.bmj.com/cgi/content/full/333/7574/912

Figure 14 BCG for Tuberculosis Note: Tuberculosis higher among two (2) dose Vaccinated versus Placebo Group 0% Effective Source: Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi; The Lancet, Volume 348, Issue 9019, Pages 17-24, 6 July 1996 Figure 15 BCG for Tuberculosis Note: In years 0-2.5 the vaccinated had double the incidence of Tuberculosis versus Placebo Group 0% Effective Source: Double blind randomized controlled trial of BCG s effectiveness on 250,000 subjects Tuberculosis Research Centre (ICMR), Chennai, India: Indian Journal of Medical Research, 110, August 1999, pp. 56-69.

Figure 16 MUMPS OUTBREAK IN HIGHLY VACCINATED POPULATION 8% 92% Vaccinated 8% Unvaccinated 92% Source: Center for Disease Control, MMWR 55 (20); May 26, 2006; pp. 559-63. 2006 Iowa Figure 17 CHICKENPOX OUTBREAK IN HIGHLY VACCINATED POPULATION 14% 86% 86% Vaccinated 14% Unvaccinated Source: Pediatrics - Vol. 113; No. 3; pp. 455-459; (2004) 2001 Oregon

Figure 18 PERTUSSIS OUTBREAK IN HIGHLY VACCINATED POPULATION 10% 90% Vaccinated 10% Unvaccinated 90% Source: N.Z. Miller; Vaccine Safety Manual; N.A. Press, Sante Fe, New Mexico; p. 140; (2008) (Refers to CDC & Official Surveillance data) 1993 Ohio Figure 19 MEASLES OUTBREAK IN HIGHLY VACCINATED POPULATION 1% 99% Vaccinated 1% Unvaccinated 99% Source: New England Journal of Medicine - Vol. 316; No. 13; pp. 771-774; (1987) 1985 Texas

FIGURE 20 - NIGERIA DIPHTHERIA REPORTED CASES (1973-1982) 1,000.00 800.00 600.00 EPI Begins Diphtheria Vaccine 400.00 200.00 0.00 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 Source: E. Ekanem; A 10-Year Review of Morbidity from Childhood Preventable Diseases in Nigeria: How Successful is the Expanded Programme of Immunization (EPI)?; Journal of Tropical Pediatrics, Vol. 34; No. 6; UK; 1988; pp. 323-328.

FIGURE 21- NIGERIA WHOOPING COUGH CASE RATES PER 100,000 (1973-1982) 500.00 400.00 300.00 EPI Begins Pertussis Vaccine 200.00 100.00 0.00 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 Source: E. Ekanem; A 10-Year Review of Morbidity from Childhood Preventable Diseases in Nigeria: How Successful is the Expanded Programme of Immunization (EPI)?; Journal of Tropical Pediatrics, Vol. 34; No. 6; UK; 1988; pp. 323-328.

FIGURE 22 - DOMINICAN REPUBLIC MEASLES CASE RATES PER 100,000 (1978-1989) 180.00 160.00 140.00 120.00 100.00 80.00 60.00 40.00 EPI Begins Measles Vaccine 20.00 0.00 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 Sources: Data for years 1978-1987 Taken from UNICEF Evaluation Publication No. 6, Santo Domingo, Dominican Republic, May 27, 1988; and Data for years 1988-1989 from personal communication from PAHO, EPI Unit, Aug. 21, 1990.

FIGURE 23 - DOMINICAN REPUBLIC DIPHTHERIA CASE RATES PER 100,000 (1978-1987) 7.00 6.00 5.00 4.00 3.00 EPI Begins Diphtheria Vaccine 2.00 1.00 0.00 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 Source: Data for years 1978-1987 Taken from UNICEF Evaluation Publication No. 6, Santo Domingo, Dominican Republic, May 27, 1988.

FIGURE 24 - DOMINICAN REPUBLIC PERTUSSIS CASE RATES PER 100,000 (1978-1989) 20.00 18.00 16.00 14.00 12.00 10.00 8.00 6.00 EPI Begins Pertussis Vaccine 4.00 2.00 0.00 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 Sources: Data for years 1978-1987 Taken from UNICEF Evaluation Publication No. 6, Santo Domingo, Dominican Republic, May 27, 1988; and Data for years 1988-1989 from personal communication from PAHO, EPI Unit, Aug. 21, 1990.

FIGURE SET III. Immunization Dangers Figures twenty-five (25) through thirty five (35) graphically illustrate that increases in the number of governmental mandated vaccine doses correlates with significant increases in death rates for children under the age of five (5); and that the practice is linked to sudden infant death syndrome; various degenerative diseases, including diabetes; and appears to cause general immune system impairment in infants and children. Evidence also points to the practice of immunization as a principal factor in the recent massive increases in neurodegenerative conditions such as autism in children.

9 FIGURE 25 - COUNTRIES & NUMBER OF VACCINE DOSES MANDATED UNDER AGE 5 MORTALITY RATES FOR 2007 8 7 6 Under Age 5 Mortality per 1,000 Live Births Mortality Increase Trendline 5 4 3 2 1 0 Under Age 5 Mortality statistics derived from: World Health Organization World Health Statistics 2009 Report http://www.who.int/whosis/whostat/en_whs09_table1.pdf & Govt. Mandated Vaccines figures derived from: Generation Rescue Inc. 2009 http://www.generationrescue.org/documents/special%20report%20autism%202.pdf

90 FIGURE 26 - UNDER AGE 5 INFLUENZA DEATHS BEFORE AND AFTER U.S. CDC MANDATES FLU VACCINES IN EARLY CHILDHOOD 80 70 Influenza Deaths Children Under Age 5 60 50 40 30 20 10 0 Latter half of 2002 C DC Mandates Early Childhood Flu Vaccines in USA 1999 2000 2001 2002 2003 Under Age 5 Influenza Mortality statistics derived from: Center for Disease Control Vital Statistics Reports covering Years 1999-2003 reported in Miller, N.Z., Vaccine Safety Manual, New Atlantean Press, Sante Fe, New Mexico, 2008, p. 97.

FIGURE 27 - PERTUSSIS VACCINE & SUDDEN INFANT DEATH SYNDROME 80% 70% 60% 50% 40% 30% Post-Pertussis Vaccination 70% of SIDS Deaths Occurred Within 3 Weeks 20% 10% 0% 0.5 1 3 7 14 21 Days Post-Vaccination 2/3 of 103 infants had been vaccinated with pertussis prior to death, of which 6.5% died within 12 hours; 13% within 24 hours; 26% within 3 days; 37%, 61% & 70% within 1, 2, & 3 weeks respectively. Source: Torch W., Neurology - 32 (4 Pt. 2) A, 1982, pp. 169-170. 4 3.5 3 2.5 2 1.5 FIGURE 28 - MEASLES VACCINE & INFLAMMATORY BOWEL DISEASES Unvaccinated Vaccinated 1 0.5 0 Ulcerative Colitis Crohn's Disease Source:The Lancet - Vol. 345; 8957; 1995, pp. 1062-1063.

Average Incidence First Five (5) years of Life Fever >40 Nederlands Vereniging Kritisch Prikken 2004 Survey Findings Ear Infections Inflammation of the Throat Aggressive Behaviour Events FIGURE 29 Fully Vaccinated No Vaccinations Convulsions/ Collapse Antibiotics Administered 0 0.5 1 1.5 2 2.5 Baby Cries Often Sickly Absolute Incidence N=543 Nederlands Vereniging Kritisch Prikken 2004 Survey Findings Eczema Asthma/ Chronic Lung Disease Allergic Reactions FIGURE 30 Fully Vaccinated No Vaccinations Aggressive Behaviour Difficulty Sleeping 0 20 40 60 80 100 120 140 160 180 Absolute Incidence (Non-Vaccinated in Relation to Vaccinated to N = 312 Per Group

BCG Mandated in Schools & Diabetes Rates Iceland Luxembourg Spain, Catalonia Belgium Netherlands Spain, Madrid FIGURE 31 NO BCG VACCINATIONS BCG VACCINATIONS Source: Infectious Disease in Clinical Practice - No. 6, pp. 449-454; (1997) England N. Ireland Scotland Denmark Norway 0 5 10 15 20 25 Type 1 per 1000,000 Children 0-14 140 120 100 Cumulative Incidence IDDM/1,000,000 UK Incidence - Insulin Dependant Diabetes Mellitus Percentage - Pertussis Immunization Coverage Source: Journal of Pediatric Endocrinology & Metabolism, 16, pp. 495-508; (2003) FIGURE 32 80 60 40 20 0 1978/74 1979/75 1980/76 1981/77 1982/78 1983/79 1984/80 1985/81 1986/82 1987/83 1988/84 1985/86

FIGURE 33 http://childhealthsafety.wordpress.com/2009/06/03/japvaxautism/ Figure based on: Kihei Terada et. al.; Alterations in epidemics and vaccination for measles during a 20 year period and a strategy for elimination in Kurashiki City, Japan; Kawasaki Medical School 2002 Mar; 76 (3):pp. 180-4. Correlated with: H. Honda et. al,; No effect of MMR withdrawal on the incidence of autism: a total population study; Journal of Child Psychology & Psychiatry; June 2005 (6); pp.572-579

25 FIGURE 34 20 18 20 16 14 15 12 10 5 Vaccine Mercury Burden & Autism Rate California, USA 1991-1997 Surveys 10 8 6 4 2 0 Rate 1991 1992 1993 1994 1995 1996 1997 Rate of Autism per 10,000 Vaccine Mercury Exposure (x 10 = Micrograms) 0 Source: Adapted from Blaxil, M., Vaccine Mercury Burden & Autism Risk (US) IOM 7/2001, http://www.healing-arts.org/children/marksslide_files/slide0003.htm

VSD: Generation Zero FIGURE 35 Source: http://www.evidenceofharm.com/ucsd.ppt#363,27,vsd: Generation Zero